US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 6.890
  • +0.070+1.03%
Close Jul 19 16:00 ET
578.52MMarket Cap-2400P/E (TTM)

Verve Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Jul 3, 2024

Based on 6 analysts giving stock ratings to Verve Therapeutics in the past 3 months

Strong Buy

  • Buy

    83.33%

  • Hold

    16.67%

  • Sell

    0.00%

Price Target

Updated: Jul 3, 2024

The average Verve Therapeutics stock price target is 25.67 with a max estimate of 35.00 and a min estimate of 15.00

Review Verve Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Jul 3, 2024

Strong Buy

  • Buy

    83.33%

  • Hold

    16.67%

  • Sell

    0.00%

Price Target

Updated: Jul 3, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg